- Cell-Based Therapy for Degenerative Retinal DiseaseMarco Zarbin
Rutgers New Jersey Medical School, Newark, NJ 07103, USA Electronic address
Trends Mol Med 22:115-34. 2016..A greater understanding of the mechanisms controlling synapse formation as well as the immunoreactivity of transplanted retinal cells is urgently needed. ..
- Ophthalmic evaluations in clinical studies of fingolimod (FTY720) in multiple sclerosisMarco A Zarbin
Institute of Ophthalmology and Visual Science, New Jersey Medical School, Newark, New Jersey 07103, USA
Ophthalmology 120:1432-9. 2013..To report outcomes of ophthalmic evaluations in clinical studies of patients receiving fingolimod (Gilenya; Novartis Pharma AG, Basel, Switzerland) for multiple sclerosis (MS)...
- PIGMENT EPITHELIUM REMOVAL AND TRANSPLANTATIONMarco Zarbin; Fiscal Year: 2003..IV: Assess long-term viability of syngeneic RPE sheet transplants onto damaged Bruch's membrane using a published in vivo RPE debridement model. ..
- Enhancing Cell Survival on Aged Bruch's MembraneMarco Zarbin; Fiscal Year: 2007..abstract_text> ..